Cabaletta Bio(CABA) - 2025 FY - Earnings Call Transcript

Cabaletta Bio (NasdaqGS:CABA) FY 2025 Conference December 03, 2025 01:45 PM ET Company ParticipantsDavid Chang - CMOSteve Nichtberger - President, CEO, and Co-founderSteven Gavel - Chief Commercial OfficerConference Call ParticipantsSamantha Semenkow - Senior Biotech AnalystSamantha SemenkowGood afternoon. I'm Samantha Semenkow, Senior Biotech Analyst here at Citi, and today it's my pleasure to be hosting Cabaletta Bio for a fireside chat at Citi's Global Healthcare Conference. I'm joined today by President ...